An audit of the HIV drug resistance testing program in Malawi.

doi:10.4314/mmj.v37i1.3

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Back to search

Article

An audit of the HIV drug resistance testing program in Malawi.

Malawi medical journal : the journal of Medical Association of Malawi - 1 Mar 2025

Kanise Hope, Nyirenda Khumbo, Bisani Pachawo, Matola Bilaal W, Makwaya Amos, Simon Katherine, Cox Carrie, Hosseinipour Mina C, Kanyama Cecilia, Worku Anteneh, Phiri Sam, Hoffman Risa M, Nyirenda Rose, Heller Tom, van Oosterhout Joep J

Abstract excerpt

Introduction: For persons failing on dolutegravir- and protease inhibitor-based antiretroviral therapy (ART) regimens, Malawi's HIV program requires confirmation of HIV drug resistance (HIVDR) before switching to next-line regimens. Approval of applications for HIVDR testing is determined by a national HIVDR committee that also provides management recommendations based on HIVDR test results. We audited HIVDR test...

Topics

Humans
HIV Infections
Malawi
Drug Resistance, Viral
Retrospective Studies
Male
Female
Viral Load
Pyridones
Adult

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Heterocyclic Compounds, 3-Ring

Piperazines

HIV-1

Anti-HIV Agents

Oxazines

Genotype

Middle Aged

Dolutegravir

Source

Open in PubMed Open full text

Identifiers

PMID: 41306355
DOI: 10.4314/mmj.v37i1.3
PMCID: PMC12153224

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An audit of the HIV drug resistance testing program in Malawi.PMID 41306355Read ↗

Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi’s National HIV Treatment ProgramSemantic proximity Read ↗

Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi.Semantic proximity Read ↗

Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi.Semantic proximity Read ↗

Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi.Semantic proximity Read ↗

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.Semantic proximity Read ↗

High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam.Semantic proximity Read ↗

Surveillance of HIV-1 drug resistance in Tanzania across the pre- and post-dolutegravir eras: A systematic review and meta-analysis.Semantic proximity Read ↗

Pre-treatment drug resistance among patients initiating antiretroviral therapy (ART) in Zimbabwe: 2008-2010.Semantic proximity Read ↗

Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes.Semantic proximity Read ↗

Virological Outcomes and Dolutegravir Resistance Mutations in HIV-infected Patients: A Multicenter Retrospective Cohort Study in MozambiqueSemantic proximity Read ↗

Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.Semantic proximity Read ↗

Monitoring of virological response and acquired HIV-1 drug resistance among patients initiating antiretroviral therapy in the Centre Region of Cameroon.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.